Back to Search
JOSHUA SORENSON, MD
MD
Hospitalist Physician
NPI: 1558998898IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
T4273(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
T4273(TX)
Education
TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Class of 2023
Research & Publications (20)
Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid.
PMID 19563861·Biochimie·2009
7-preclinical
Measurement of bone mineral in vivo: an improved method. 1963.
PMID 19287886·Salud Publica Mex·2009
8-other
Relationship between self-efficacy and physical activity among patients with type 2 diabetes.
PMID 19156510·J Behav Med·2009
8-other
Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
PMID 18929354·Am J Ophthalmol·2009
3-trial
Rapid whole-genome mutational profiling using next-generation sequencing technologies.
PMID 18775913·Genome Res·2008
8-other
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.
PMID 18329624·Am J Ophthalmol·2008
5-case
Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.
PMID 18301024·Retina·2008
5-case
Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less toxic than cisplatin therapy.
PMID 17584059·Curr Med Chem·2007
6-review
Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.
PMID 17891007·Retina·2007
8-other
Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
PMID 16963850·Retina·2006
2-rct
Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
PMID 16963851·Retina·2006
3-trial
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
PMID 16603955·Retina·2006
8-other
Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
PMID 16606873·Arch Ophthalmol·2006
8-other
Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalicylate)4(ethanol)4].
PMID 16814979·Toxicol In Vitro·2006
7-preclinical
Using formative research to develop a context-specific approach to informed consent for clinical trials.
PMID 19385837·J Empir Res Hum Res Ethics·2006
8-other
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
PMID 16508427·Retina·2006
8-other
Development of an interactive computer-assisted instruction (ICAI) program for patient prenatal genetic screening and carrier testing for use in clinical settings.
PMID 16257626·Patient Educ Couns·2005
8-other
Large spot transpupillary thermotherapy for occult choroidal neovascularization.
PMID 16157814·Arch Ophthalmol·2005
8-other
Assessment of an interactive computer-based patient prenatal genetic screening and testing education tool.
PMID 16148208·Health Educ Behav·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1600 WALLACE BLVD
AMARILLO, TX 79106 - Phone
- (806) 212-2000
Quick Facts
- NPI
- 1558998898
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile